Renal cell carcinoma in young and old patients--is there a difference?

The Journal of Urology
R Houston ThompsonKarim Touijer

Abstract

Renal cell carcinoma is rare in patients younger than 40 years and conflicting data regarding presentation and outcome are present in the literature. We reviewed our experience with young patients with renal cell carcinoma and compared them to their older counterparts. We identified 1,720 patients 18 to 79 years old who were treated with partial or radical nephrectomy for renal cell carcinoma between 1989 and 2005. Patients were grouped according to age and outcome analysis was performed. Of the 1,720 patients with renal cell carcinoma 89 (5%), 672 (39%) and 959 (56%) were younger than 40, 40 to 59 and 60 to 79 years old, respectively. There were no significant differences in sex, tumor size, TNM stage or multifocality by age group. However, patients younger than 40 years were significantly more likely to present with symptomatic tumors (p = 0.028). Additionally, there were significant differences in histology by age (p <0.001), that is chromophobe histology decreased while papillary histology increased with age. Despite similar tumor sizes in each age group the percent of patients treated with partial nephrectomy decreased with age. Of patients younger than 40 years 49% were treated with partial nephrectomy compared with 35% a...Continue Reading

References

Apr 1, 1985·Urology·M SchiffB Lytton
Apr 24, 1993·Lancet·A de la RochefordiereA Fourquet
Nov 14, 2002·Urology·Hazem I Abou El FettouhAndrew C Novick
Dec 11, 2003·The Journal of Urology·S E EggenerJ R Rubenstein
May 6, 2004·The Journal of Urology·Ricardo F Sánchez-OrtizChristopher G Wood
Sep 24, 2004·The New England Journal of Medicine·Alan S GoChi-yuan Hsu
Nov 10, 2006·European Urology·Xavier TaccoenUNKNOWN Oncology Committee of the Association Française d'Urologie
Dec 12, 2007·Cancer·David C MillerUNKNOWN Urologic Diseases in America Project

❮ Previous
Next ❯

Citations

Nov 15, 2012·International Urogynecology Journal·Oz Harmanli, Beril Yuksel
Apr 5, 2011·Medical Oncology·Burçin BudakoğluNurullah Zengin
Mar 26, 2010·Journal of Endourology·Tom DeklajKevin C Zorn
Sep 8, 2010·Journal of Endourology·Joseph A PettusRonald J Zagoria
Aug 5, 2011·Drugs & Aging·Sumanta K PalRobert A Figlin
Oct 25, 2012·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Lutfiye DemirMustafa Oktay Tarhan
Jan 18, 2014·British Journal of Cancer·T E HutsonR J Motzer
Oct 25, 2013·Advances in Therapy·Christoph von KlotAxel S Merseburger
Nov 16, 2011·Journal of Cancer Research and Clinical Oncology·Muhammed MubarakSyed Adeeb Ul Hassan Rizvi
May 15, 2012·The Journal of Urology·Miki N HewM Pilar Laguna
Jan 31, 2012·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·T P GhoneimL Zini
Apr 12, 2011·Urology·Paul Russo
Mar 20, 2010·The Journal of Urology·William T LowrancePaul Russo
Jul 23, 2011·Urology·Max KatesJames McKiernan
Aug 27, 2013·The Journal of Urology·Atiqullah AzizUNKNOWN Members of the CORONA Project and the Young Academic Urologists Renal Cancer Group
Jan 22, 2015·Current Urology Reports·Michael Daugherty, Gennady Bratslavsky
Jul 23, 2016·Medical Oncology·Hideaki MiyakeMasato Fujisawa
May 2, 2017·Rare Tumors·Prajwal DhakalVijaya Raj Bhatt
Sep 19, 2018·Journal of Primary Care & Community Health·Allen L PimientaRobert G Fish
Nov 9, 2016·Journal of Korean Medical Science·Ho Won KangUNKNOWN KOrean Renal Cell Carcinoma (KORCC) Group
Apr 11, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Atif Ali HashmiNaveen Faridi
Apr 29, 2020·Journal of Primary Care & Community Health·Gayatri Setia, Ilan Kedan
Jul 10, 2016·Clinical Chemistry and Laboratory Medicine : CCLM·Ashley Di MeoGeorge M Yousef
Jul 2, 2020·International Urology and Nephrology·Mehmet Çağlar ÇakıcıAsıf Yıldırım
Mar 24, 2018·F1000Research·Shahzaib NabiElaine T Lam
Jan 10, 2020·Journal of Histotechnology·Marta WoźniakSiddarth Agrawal
May 13, 2020·International Journal of Clinical Oncology·Kazuyuki NumakuraTomonori Habuchi
Mar 25, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Stuart C GordonLois Lamerato

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.